| 1 | 100 µg Brimonidine Tartrate Implant | [1] Brimonidine Brimonidine | [2] D02076
D02076
(Name: Brimonidine tartrate),
D07540
(Name: Brimonidine) | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 90 90 |
| 2 | 200 µg Brimonidine Tartrate Implant | [1] Brimonidine Brimonidine | [2] D02076
D02076
(Name: Brimonidine tartrate),
D07540
(Name: Brimonidine) | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 90 90 |
| 3 | 400 µg Brimonidine Tartrate Implant | [1] Brimonidine Brimonidine | [2] D02076
D02076
(Name: Brimonidine tartrate),
D07540
(Name: Brimonidine) | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 90 90 |
| 4 | Brimonidine | [1] Brimonidine Brimonidine | [2] D02076
D02076
(Name: Brimonidine tartrate),
D07540
(Name: Brimonidine) | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [2] 13 13, 90 |
| 5 | Brimonidine tartrate | [1] Brimonidine Brimonidine | [2] D02076
D02076
(Name: Brimonidine tartrate),
D07540
(Name: Brimonidine) | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [2] 13 13, 90 |
| 6 | Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimo PS DDS) Applicator System | [1] Brimonidine Brimonidine | [2] D02076
D02076
(Name: Brimonidine tartrate),
D07540
(Name: Brimonidine) | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 90 90 |